ACLAX | VMVAX | ACLAX / VMVAX | |
Total Expense Ratio | 1.22 | 0.07 | 1,743% |
Annual Report Gross Expense Ratio | 1.22 | 0.07 | 1,743% |
Fund Existence | 21 years | 14 years | - |
Gain YTD | 8.575 | 6.858 | 125% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7.03B | 31B | 23% |
Annual Yield % from dividends | 1.30 | 2.22 | 59% |
Returns for 1 year | 0.11 | 6.27 | 2% |
Returns for 3 years | 9.47 | 27.32 | 35% |
Returns for 5 years | 16.97 | 66.64 | 25% |
Returns for 10 years | 21.87 | 107.59 | 20% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FCO | 6.70 | 0.05 | +0.75% |
abrdn Global Income Fund | |||
USMV | 94.26 | 0.23 | +0.24% |
iShares MSCI USA Min Vol Factor ETF | |||
JHCP | 25.25 | -0.06 | -0.25% |
JHancock Core Plus Bond ETF | |||
AVES | 55.55 | -0.35 | -0.62% |
Avantis Emerging Markets Value ETF | |||
AMDY | 7.87 | -0.25 | -3.08% |
YieldMax AMD Option Income Strategy ETF |